Fig. 4From: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patientsMCM2 and NUP37 overexpression correlated with worse survival in HCC patients. AāB Box plots showing mRNA of MCM2 or NUP37 significantly correlates with the clinical stage of HCC. * pā<ā0.05, *** pā<ā0.001, based on Wilcoxon test. CāD KaplanāMeier survival analysis was performed to assess the impact of MCM2 and NUP37 on survival of HCC patients from 3 independent cohorts. p is based on log-rank test. TCGA cohort (nā=ā370); NODE cohort (nā=ā150), and ZHE YI Cohort (nā=ā300). EāF Forest plots showing Cox univariate and multivariate survival analyses results in ZHE YI CohortBack to article page